https://www.biospace.com/restorbio-presents-additional-phase-2b-data-at-the-american-thoracic-society-international-conference-for-rtb101-as-a-potential-immunotherapy-to-reduce-the-incidence-of-respiratory-tract-infections
resTORbio Presents Additional Phase 2b Data at the American Thoracic Society International...
May 21, 2019 - RTB101 10 mg once daily was observed to reduce the rate of laboratory-confirmed Respiratory Tract Infections (RTIs) by 78.7% (p=0.001) and the rate of all RTIs...
the american thoracic society
https://www.prnewswire.com/news-releases/altesa-biosciences-selected-for-oral-presentation-at-the-american-thoracic-society-2026-international-congress-302758236.html
Altesa BioSciences Selected for Oral Presentation at the American Thoracic Society 2026...
/PRNewswire/ -- Altesa BioSciences, a clinical-stage pharmaceutical company dedicated to preventing and treating the leading cause of COPD and asthma...
the american thoracic societyoral presentation
https://www.biospace.com/korro-presents-additional-preclinical-data-for-krro-110-at-the-american-thoracic-society-2024-international-conference
Korro Presents Additional Preclinical Data for KRRO-110 at the American Thoracic Society 2024...
May 20, 2024 - Korro Bio, Inc. (Korro) (Nasdaq: KRRO) is presenting new preclinical data demonstrating the specificity and the completion of a genetic mouse study and...
the american thoracic society